Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Arg | - |
Homo sapiens | |
beta-Ala | weak | Homo sapiens | |
His | weak | Homo sapiens | |
Lys | - |
Homo sapiens | |
Orn | weak | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
amniotic fluid | - |
Homo sapiens | - |
fibroblast | foreskin | Homo sapiens | - |
lung | plasma membrane and fibroblasts | Homo sapiens | - |
lung cancer cell | metastatic | Homo sapiens | - |
placenta | microvilli | Homo sapiens | - |
plasma | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
assay | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg + H2O | i.e. bradykinin, removal of C-terminal Arg | Homo sapiens | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe + Arg | - |
? |